Vanguard Group’s Elevance Health ELV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $8.89B | Buy |
|
|||||
|
2025
Q1 | $9.64B | Buy |
|
|||||
|
2024
Q4 | $7.93B | Buy |
|
|||||
|
2024
Q3 | $11.1B | Buy |
|
|||||
|
2024
Q2 | $11.5B | Sell |
|
|||||
|
2024
Q1 | $11B | Buy |
|
|||||
|
2023
Q4 | $10B | Buy |
|
|||||
|
2023
Q3 | $9.23B | Sell |
|
|||||
|
2023
Q2 | $9.48B | Sell |
|
|||||
|
2023
Q1 | $9.87B | Sell |
|
|||||
|
2022
Q4 | $11B | Buy |
|
|||||
|
2022
Q3 | $9.65B | Buy |
|
|||||
|
2022
Q2 | $10.2B | Buy |
|
|||||
|
2022
Q1 | $10.2B | Buy |
|
|||||
|
2021
Q4 | $8.77B | Sell |
|
|||||
|
2021
Q3 | $7.06B | Buy |
|
|||||
|
2021
Q2 | $7.22B | Buy |
|
|||||
|
2021
Q1 | $6.76B | Sell |
|
|||||
|
2020
Q4 | $6.09B | Sell |
|
|||||
|
2020
Q3 | $5.19B | Sell |
|
|||||
|
2020
Q2 | $5.17B | Sell |
|
|||||
|
2020
Q1 | $4.54B | Buy |
|
|||||
|
2019
Q4 | $5.89B | Sell |
|
|||||
|
2019
Q3 | $4.69B | Buy |
|
|||||
|
2019
Q2 | $5.49B | Buy |
|
|||||
|
2019
Q1 | $5.55B | Buy |
|
|||||
|
2018
Q4 | $5.02B | Buy |
|
|||||
|
2018
Q3 | $5.13B | Buy |
|
|||||
|
2018
Q2 | $4.33B | Buy |
|
|||||
|
2018
Q1 | $3.95B | Buy |
|
|||||
|
2017
Q4 | $4.01B | Sell |
|
|||||
|
2017
Q3 | $3.41B | Buy |
|
|||||
|
2017
Q2 | $3.35B | Buy |
|
|||||
|
2017
Q1 | $2.87B | Buy |
|
|||||
|
2016
Q4 | $2.39B | Buy |
|
|||||
|
2016
Q3 | $2.05B | Buy |
|
|||||
|
2016
Q2 | $2.1B | Buy |
|
|||||
|
2016
Q1 | $2.17B | Buy |
|
|||||
|
2015
Q4 | $2.11B | Buy |
|
|||||
|
2015
Q3 | $2.08B | Buy |
|
|||||
|
2015
Q2 | $2.43B | Buy |
|
|||||
|
2015
Q1 | $2.28B | Buy |
|
|||||
|
2014
Q4 | $1.81B | Buy |
|
|||||
|
2014
Q3 | $1.7B | Buy |
|
|||||
|
2014
Q2 | $1.52B | Buy |
|
|||||
|
2014
Q1 | $1.39B | Sell |
|
|||||
|
2013
Q4 | $1.31B | Buy |
|
|||||
|
2013
Q3 | $1.18B | Buy |
|
|||||
|
2013
Q2 | $1.12B | Buy |
|